Clinical trials with gene-editing tools to start: Tang Prize laureate
04/22/2018 06:50 PM
Chinese American biologist and 2016 Tang Prize winner in biopharmaceutical science Feng Zhang (張鋒) said Saturday that initial clinical trials using gene-editing technology to help people with genetic diseases are expected to start this year or next.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Cause of 5 deaths in Taoyuan fire determined, blaze source unclear
08/31/2025 09:17 PM - Society
Use of ultrasound in Chinese traditional medicine possible by year-end
08/31/2025 09:10 PM - Culture
CKS Memorial Hall holds concert on Taiwan's censored songs
08/31/2025 09:09 PM - Science & Tech
4th Taiwan Tech Summit in Silicon Valley to take place Sept. 20
08/31/2025 08:33 PM - Culture
VP Hsiao joins Washington Nationals' Taiwan Heritage Day celebrations
08/31/2025 07:14 PM